India to send hydroxychloroquine in 13 countries

At first, 13 countries are approved to receive the anti-malaria drug includes the US, Spain, Germany, Nepal, Bhutan, Afghanistan, Maldives, Bangladesh, Seychelles, Mauritius, Brazil, Dominican Republic and Bahrain.

HCQ is being sent to the countries which are more hit by the Coronavirus. The Ministry of External Affairs has prepared an inventory of these countries which have sought help from India.

Several countries have approached to India seeking help in terms of medicines, protective medical gear, as well as medical devices.

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre

    US FDA launches expedited IND Pilot, begins accepting applications

    US FDA launches expedited IND Pilot, begins accepting applications